Description
Product details
CINASELECT 60: Comprehensive Guide to Cinacalcet 60 mg Tablets Product Overview CINASELECT 60 is a pharmaceutical formulation containing Cinacalcet hydrochloride 60 mg as its active ingredient. This medication represents a significant advancement in the management of calcium metabolism disorders, particularly in patients with chronic kidney disease and parathyroid conditions. As a calcimimetic agent, CINASELECT 60 works by mimicking the action of calcium on tissues, helping to restore hormonal balance and mineral homeostasis in the body. The 60 mg dosage strength offers an effective therapeutic option for patients requiring moderate to higher-level intervention in managing parathyroid hormone levels and associated calcium imbalances. CINASELECT 60 is manufactured under strict quality control standards, ensuring consistency, purity, and efficacy in every tablet. Understanding How CINASELECT 60 Works CINASELECT 60 operates through a sophisticated mechanism that targets the calcium-sensing receptors located on the surface of parathyroid gland cells. These receptors play a crucial role in regulating parathyroid hormone secretion, which in turn controls calcium and phosphorus levels in the bloodstream. When you take CINASELECT 60, the active ingredient cinacalcet binds to these calcium-sensing receptors, increasing their sensitivity to extracellular calcium. This enhanced sensitivity tricks the parathyroid glands into “thinking” there is more calcium present in the blood than there actually is. As a result, the glands reduce their production and release of parathyroid hormone (PTH). By lowering PTH levels, CINASELECT 60 subsequently reduces calcium levels in the blood and decreases the amount of phosphorus absorbed from the intestines. This cascade effect helps restore the delicate mineral balance that is often disrupted in patients with kidney disease or parathyroid disorders. Primary Therapeutic Uses Secondary Hyperparathyroidism in Chronic Kidney Disease The primary indication for CINASELECT 60 is the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) who are on dialysis. When kidneys fail to function properly, they cannot adequately regulate calcium and phosphorus levels, leading to excessive parathyroid hormone production. This condition can result in serious complications including bone disease, cardiovascular calcification, and increased mortality risk. CINASELECT 60 helps manage this condition by controlling PTH levels, thereby reducing the risk of bone complications such as osteitis fibrosa cystica and preventing the dangerous deposition of calcium in blood vessels and soft tissues. Hypercalcemia in Parathyroid Carcinoma CINASELECT 60 is also indicated for treating hypercalcemia (elevated blood calcium levels) in patients with parathyroid carcinoma, a rare malignant tumor of the parathyroid glands. In these cases, the medication helps control the dangerously high calcium levels that can lead to kidney stones, bone pain, digestive issues, and neurological symptoms. Primary Hyperparathyroidism For patients with severe hypercalcemia due to primary hyperparathyroidism who cannot undergo parathyroidectomy or for whom surgery has failed, CINASELECT 60 offers a valuable medical management option. This provides relief for patients who are not surgical candidates due to advanced age, comorbidities, or other contraindications. Key Benefits of CINASELECT 60 Effective PTH Control Clinical studies have demonstrated that CINASELECT 60 significantly reduces parathyroid hormone levels in a dose-dependent manner. This reduction helps prevent the cascade of complications associated with elevated PTH, including bone mineral loss and cardiovascular calcification. Improved Calcium-Phosphorus Balance By reducing PTH secretion, CINASELECT 60 helps normalize serum calcium and phosphorus levels. This is particularly important in dialysis patients, where mineral imbalances can lead to serious complications affecting bone health, cardiovascular function, and overall quality of life. Reduced Cardiovascular Risk Elevated calcium and phosphorus levels contribute to vascular calcification, a major risk factor for cardiovascular disease in patients with chronic kidney disease. By managing these mineral levels, CINASELECT 60 may help reduce the risk of cardiovascular complications, which are the leading cause of death in dialysis patients. Bone Health Preservation Uncontrolled secondary hyperparathyroidism leads to renal osteodystrophy, a condition characterized by abnormal bone metabolism. CINASELECT 60 helps protect bone integrity by normalizing PTH levels, potentially reducing fracture risk and preserving bone mineral density. Alternative to Surgery For patients with primary hyperparathyroidism or parathyroid carcinoma who cannot undergo surgery, CINASELECT 60 provides an effective medical management option. This is particularly valuable for elderly patients or those with multiple comorbidities that make surgery risky. Quality of Life Improvement By controlling symptoms associated with hypercalcemia and hyperparathyroidism, such as bone pain, muscle weakness, fatigue, and digestive issues, CINASELECT 60 can significantly improve patients' overall quality of life and functional capacity. Convenient Oral Administration CINASELECT 60 is administered orally, making it more convenient than injectable alternatives. This allows for outpatient management and reduces the burden on healthcare facilities and patients. Potential Side Effects and Adverse Reactions Common Side Effects Patients taking CINASELECT 60 may experience several common side effects, which typically include nausea and vomiting, occurring in approximately 20-30% of patients. These gastrointestinal symptoms are usually mild to moderate and may improve over time as the body adjusts to the medication. Diarrhea is another frequent complaint, affecting roughly 20% of users. Some patients also report muscle pain or myalgia, dizziness, loss of appetite, and asthenia (general weakness or fatigue). Serious Side Effects Requiring Medical Attention Hypocalcemia: The most significant risk associated with CINASELECT 60 is the development of low calcium levels in the blood. Severe hypocalcemia can lead to paresthesias (tingling sensations), muscle cramps or spasms, tetany, seizures, and QT interval prolongation on electrocardiogram, which can predispose to dangerous heart rhythm abnormalities. Gastrointestinal Bleeding: There have been reports of gastrointestinal hemorrhage in patients taking cinacalcet, particularly in those with risk factors such as gastritis, ulcers, or concurrent use of other medications that increase bleeding risk. Adynamic Bone Disease: Oversuppression of PTH can lead to adynamic bone disease, a condition where bone turnover becomes abnormally low, potentially weakening bones despite normalized calcium levels. Cardiovascular Effects: Some patients may experience worsening heart failure or arrhythmias, particularly if hypocalcemia develops. Close monitoring is essential in patients with underlying cardiovascular disease. Allergic Reactions: Though rare, hypersensitivity reactions including rash, urticaria, and angioedema have been reported. Precautions and Contraindications CINASELECT 60 should not be used in patients with serum calcium levels below the normal range. It requires careful dose adjustment and monitoring in patients with hepatic impairment. The medication may interact with drugs metabolized by the CYP2D6 enzyme system and with medications that affect gastric pH. Pregnant or breastfeeding women should use CINASELECT 60 only if clearly needed, as its safety in these populations has not been fully established. Regular monitoring of serum calcium, phosphorus, and PTH levels is essential throughout treatment. Dosage and Administration Guidelines CINASELECT 60 should be taken orally with food or shortly after a meal, as this improves absorption and reduces gastrointestinal side effects. Tablets should be swallowed whole and not crushed, chewed, or divided. The typical starting dose for secondary hyperparathyroidism is lower than 60 mg, with gradual titration based on PTH and calcium levels. The 60 mg strength is often used as part of the dose escalation process or as a maintenance dose once optimal PTH control is achieved. Dose adjustments should be made no more frequently than every two to four weeks, as it takes this long to see the full effect of a dose change on PTH levels. Treatment should be individualized based on laboratory values and clinical response. Monitoring Requirements Patients on CINASELECT 60 require regular monitoring of serum calcium, phosphorus, and intact PTH levels. Calcium levels should be checked within one week of starting treatment or after any dose adjustment, and then monthly once stable. PTH levels should be measured one to four weeks after initiation or dose adjustment, then every one to three months during maintenance therapy. Additionally, patients should be monitored for signs and symptoms of hypocalcemia, particularly during the initial treatment period. Electrocardiogram monitoring may be appropriate in patients at risk for QT prolongation. Storage and Handling CINASELECT 60 should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed to protect from humidity. Keep out of reach of children and pets. Do not use past the expiration date printed on the package. Conclusion CINASELECT 60 (Cinacalcet 60 mg) represents a valuable therapeutic option in the management of secondary hyperparathyroidism associated with chronic kidney disease, hypercalcemia in parathyroid carcinoma, and primary hyperparathyroidism in patients who cannot undergo surgery. Its unique mechanism as a calcimimetic agent provides effective control of parathyroid hormone secretion, helping to restore mineral balance and prevent serious complications. The benefits of CINASELECT 60 extend beyond simple laboratory value normalization. By controlling PTH, calcium, and phosphorus levels, this medication helps preserve bone health, reduce cardiovascular calcification risk, and improve overall quality of life for patients dealing with complex metabolic disorders. For patients who are not surgical candidates, CINASELECT 60 offers hope and effective symptom management. However, like all medications, CINASELECT 60 must be used judiciously under close medical supervision. The risk of hypocalcemia and other potential side effects necessitates regular laboratory monitoring and open communication between patients and healthcare providers. Patients should report any concerning symptoms promptly and attend all scheduled follow-up appointments.
![Bromfenac ophthalmic solution 0.09% w/v is a prescription non-steroidal anti-inflammatory drug (NSAID) eye drop used primarily to treat pain and inflammation following cataract surgery and to reduce the risk of post-operative cystoid macular edema. Unlike corticosteroid eye drops, bromfenac is not a steroid — it works by inhibiting the cyclooxygenase (COX) enzyme, blocking the production of prostaglandins that drive inflammation, redness, and pain. A key advantage of bromfenac is its once-daily dosing, compared to the multiple daily doses required by many other topical NSAIDs and steroids, which improves ease of use during post-surgical recovery. Common side effects include mild burning or stinging on instillation and temporary blurred vision, while rare but serious risks include corneal complications with prolonged or inappropriate use. It is a Schedule H prescription-only medicine in India.
What Is Bromfenac Ophthalmic Solution 0.09% w/v?
Bromfenac ophthalmic solution 0.09% w/v is a topical non-steroidal anti-inflammatory drug (NSAID) formulated for use in the eye. It is most commonly prescribed to manage inflammation and pain following ocular surgery, particularly cataract surgery, and is also used to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after intraocular procedures.
As an NSAID, bromfenac differs fundamentally from corticosteroid eye drops. It does not carry the risk of raising intraocular pressure (IOP) that steroids do, making it a valuable option — often used alongside or instead of a steroid — in the post-surgical care protocol, depending on the surgeon's assessment.
One of bromfenac's most notable practical advantages is its once-daily dosing schedule, which sets it apart from several other ophthalmic NSAIDs that require two to four applications per day. This simplified regimen can improve patient adherence during the post-operative recovery period.
How Does Bromfenac Work? (Mechanism of Action)
Tissue injury response – Ocular surgery and inflammation trigger the release of arachidonic acid from damaged cell membranes.
Cyclooxygenase (COX) enzyme activity – The COX-1 and COX-2 enzymes convert arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and vascular permeability.
COX inhibition by bromfenac – Bromfenac inhibits both COX-1 and COX-2 enzymes, blocking the prostaglandin synthesis pathway.
Reduced inflammation and pain – With prostaglandin production suppressed, inflammation, redness, and post-surgical discomfort are reduced.
Protection against macular edema – By limiting prostaglandin-driven vascular permeability, bromfenac also helps lower the risk of fluid accumulation in the macula following surgery.
Clinical Indications
IndicationDetailsPost-operative inflammationPrimary use following cataract surgeryPost-operative pain managementReduces surgical site discomfort during recoveryPrevention of post-operative cystoid macular edemaUsed prophylactically around the time of cataract surgeryAdjunct to steroid therapySometimes used alongside corticosteroid drops for comprehensive post-surgical control
Dosage & Administration
ParameterRecommendationStandard doseOne drop in the operated eye, once dailyTimingOften started shortly before surgery and continued through the recovery period, as directedDurationTypically a defined post-operative course as prescribed by your ophthalmic surgeonContact lensesAvoid wearing contact lenses during the immediate post-operative period unless advised otherwiseMissed doseApply as soon as remembered; do not double the next doseCombination useMay be prescribed alongside antibiotic and/or steroid eye drops as part of a full post-surgical regimen — space applications as directed
Note: Always follow your surgeon's specific pre- and post-operative dosing schedule, as timing around the surgery date is clinically important.
Key Benefits
Effectively reduces post-surgical pain and inflammation without the IOP-related risks of steroids
Once-daily dosing improves convenience and adherence compared to multi-dose NSAID or steroid regimens
Helps lower the risk of post-operative cystoid macular edema, a potentially vision-affecting complication
Can be used alongside steroid and antibiotic eye drops as part of a comprehensive post-surgical protocol
Generally does not raise intraocular pressure, unlike corticosteroid alternatives
Supports a smoother, more comfortable post-operative recovery experience
Precautions
Use strictly as directed by your ophthalmic surgeon, particularly regarding timing before and after surgery
Use with caution in patients with known bleeding disorders or those taking medications that increase bleeding tendency, as NSAIDs can affect clotting
Rare but serious corneal complications (including delayed healing or, very rarely, corneal thinning) have been reported with prolonged or inappropriate NSAID use — report any unusual eye pain or vision change immediately
Not recommended for patients with known hypersensitivity to bromfenac or other NSAIDs
Caution advised in patients with complicated ocular surgeries, pre-existing corneal disease, or dry eye, as these may increase sensitivity to corneal side effects
Avoid contact lens wear during the treatment period unless specifically advised by your doctor
Inform your doctor of all other eye medications and systemic drugs, especially blood thinners
Side Effects
Common (Usually Mild and Temporary)
Mild burning or stinging sensation on instillation
Temporary blurred vision
Eye redness
Eye discomfort or itching
Less Common / Serious (Consult Your Doctor Promptly)
Persistent or worsening eye pain
Delayed corneal healing
Rare corneal complications, including corneal thinning or perforation with prolonged/inappropriate use
Increased risk of bleeding at the ocular surface in susceptible individuals
Signs of an allergic reaction (swelling, itching, rash)
Discontinue and contact your ophthalmologist immediately if any serious or persistent symptom develops.
Comparison: Bromfenac vs. Other Post-Surgical Anti-Inflammatory Options
TreatmentClassDosing FrequencyKey ConsiderationBromfenac ophthalmic solution 0.09%NSAIDOnce dailyConvenient dosing; no IOP risk; rare corneal risk with prolonged usePrednisolone acetateCorticosteroidMultiple times dailyEffective anti-inflammatory; carries IOP and cataract risk with prolonged useKetorolac ophthalmic solutionNSAIDMultiple times dailySimilar NSAID mechanism; more frequent dosing than bromfenacNepafenac ophthalmic suspensionNSAID (prodrug)1–3 times daily depending on formulationAlternative NSAID option; dosing varies by strength
Key Statistics (Placeholder — Pending Clinical Reviewer Verification)
MetricValueReported reduction in post-operative cystoid macular edema incidence with prophylactic NSAID use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery bromfenac therapy[Placeholder – insert verified reference range]Reported rate of corneal adverse events with appropriate short-course use[Placeholder – insert epidemiological reference]
All statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.
Expert Insight
[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]
Price of Bromfenac Ophthalmic Solution 0.09% w/v
The price of bromfenac ophthalmic solution 0.09% w/v varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.
Prescription only – consult your doctor.
Conclusion
Bromfenac ophthalmic solution 0.09% w/v has become a widely used part of modern post-cataract-surgery care, offering effective pain and inflammation control along with a meaningful reduction in the risk of post-operative cystoid macular edema — all with the convenience of once-daily dosing. As an NSAID rather than a steroid, it avoids the intraocular pressure concerns associated with corticosteroid therapy, though it carries its own specific precautions, particularly around rare corneal complications with prolonged or inappropriate use. Used exactly as directed by your ophthalmic surgeon, within the prescribed post-operative window, bromfenac supports a smoother, more comfortable surgical recovery.
Frequently Asked Questions
1. What is bromfenac ophthalmic solution 0.09% used for?
It is used to treat pain and inflammation following cataract surgery and to help reduce the risk of post-operative cystoid macular edema, a swelling of the central retina that can occur after eye surgery.
2. Is bromfenac a steroid?
No. Bromfenac is a non-steroidal anti-inflammatory drug (NSAID). It works by inhibiting the cyclooxygenase (COX) enzyme rather than acting through the steroid pathway, and it does not carry the intraocular pressure risks associated with corticosteroids.
3. How often should bromfenac eye drops be used?
Bromfenac ophthalmic solution 0.09% is typically used once daily in the operated eye, making it more convenient than many other post-surgical eye drops that require multiple daily doses.
4. How long is bromfenac used after cataract surgery?
The duration is determined by your ophthalmic surgeon based on your individual recovery, often continuing through a defined post-operative period as part of your overall surgical care protocol.
5. Can bromfenac be used with steroid eye drops?
Yes, bromfenac is often prescribed alongside corticosteroid and/or antibiotic eye drops as part of a comprehensive post-surgical regimen, with applications spaced as directed by your doctor.
6. What are the side effects of bromfenac eye drops?
Common side effects include mild burning or stinging upon application, temporary blurred vision, and eye redness. Rare but serious effects can include delayed corneal healing or corneal complications with prolonged or inappropriate use.
7. Does bromfenac raise eye pressure?
No, as an NSAID, bromfenac does not typically raise intraocular pressure the way corticosteroid eye drops can, which is one of its key advantages in post-surgical care.
8. Can bromfenac cause corneal problems?
Rare but serious corneal complications, including delayed healing or corneal thinning, have been reported with prolonged or inappropriate NSAID use. Any unusual eye pain or vision change should be reported to your doctor immediately.
9. Is bromfenac safe for people on blood thinners?
NSAIDs like bromfenac can affect bleeding tendency, so patients on blood-thinning medications or with known bleeding disorders should inform their doctor before starting treatment.
10. Can contact lenses be worn while using bromfenac?
It is generally advised to avoid wearing contact lenses during the post-operative treatment period unless your ophthalmologist specifically advises otherwise.
11. What happens if I miss a dose of bromfenac?
Apply the missed dose as soon as you remember, unless it is nearly time for your next scheduled dose, in which case skip the missed dose. Do not double up doses.
12. How is bromfenac different from ketorolac eye drops?
Both are NSAIDs with a similar mechanism of action, but bromfenac typically requires only once-daily dosing, while ketorolac usually requires multiple applications per day.
13. Can bromfenac prevent macular edema after cataract surgery?
Bromfenac is commonly used prophylactically around the time of cataract surgery to help reduce the risk of post-operative cystoid macular edema, a recognized complication of intraocular surgery.
14. Is bromfenac safe for long-term use?
Bromfenac is generally prescribed for a defined post-operative course rather than continuous long-term use, and prolonged or unsupervised use should be avoided due to rare corneal risks.
15. Who should not use bromfenac eye drops?
Patients with known hypersensitivity to bromfenac or other NSAIDs, or those with certain pre-existing corneal or bleeding conditions, should use bromfenac only under close medical supervision, if at all.
16. Does bromfenac cause blurred vision?
Temporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.
17. Can bromfenac be used before cataract surgery as well as after?
Yes, bromfenac is often started shortly before surgery and continued through the post-operative recovery period, following the specific schedule set by your ophthalmic surgeon.](https://productimages.withfloats.com/tile/6a50b1b32d7a16f0f95be110.png)
![Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India.
What Is Loteprednol Etabonate Ophthalmic Suspension?
Loteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids.
This suspension is commonly prescribed for:
Managing inflammation following eye surgery, such as cataract surgery
Treating allergic conjunctivitis, including seasonal allergic conjunctivitis
Certain anterior segment inflammatory conditions, such as uveitis, under specialist supervision
Giant papillary conjunctivitis and other steroid-responsive ocular surface conditions
Because of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary.
How Does Loteprednol Etabonate Work? (Mechanism of Action)
Corticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes.
Suppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort.
Reduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling.
Ester-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure.
Localized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration.
Clinical Indications
IndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist
Not indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition.
Dosage & Administration
ParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose
Important: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended.
Key Benefits
Effective anti-inflammatory action for a range of steroid-responsive ocular conditions
Ester-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids
Useful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring
Suitable for both post-surgical inflammation control and allergic conjunctivitis management
Available in a suspension formulation designed for good ocular surface contact
Often used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens
Precautions
Use strictly under ophthalmologist supervision — this is not an over-the-counter product
Not suitable for viral, fungal, or mycobacterial eye infections
Even with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended
Extended use may increase the risk of cataract formation, as with other ophthalmic steroids
May mask signs of infection or delay wound healing if used inappropriately
Inform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting
Shake the suspension well before each use for accurate dosing
Avoid touching the dropper tip to the eye or any surface
Side Effects
Common (Usually Mild and Temporary)
Burning or stinging sensation on instillation
Blurred vision immediately after application
Eye discomfort or a foreign-body sensation
Mild eye redness
Less Common / Serious (Consult Your Doctor Promptly)
Elevated intraocular pressure (comparatively less frequent than with older steroids, but still possible)
Delayed wound healing
Signs of secondary or masked ocular infection
Cataract progression with prolonged use
Allergic reaction (eyelid swelling, itching, rash)
Discontinue and consult your ophthalmologist promptly if any serious symptom develops.
Comparison: Loteprednol vs. Other Ophthalmic Corticosteroids
TreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk
Key Statistics (Placeholder — Pending Clinical Reviewer Verification)
MetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range]
All statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.
Expert Insight
[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]
Price of Loteprednol Etabonate Ophthalmic Suspension
The price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.
Prescription only – consult your doctor.
Conclusion
Loteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy.
Frequently Asked Questions
1. What is loteprednol etabonate ophthalmic suspension used for?
It is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance.
2. Is loteprednol a steroid?
Yes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision.
3. How long can I use loteprednol eye drops?
Loteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use.
4. Does loteprednol raise eye pressure?
Loteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended.
5. Can loteprednol cause cataracts?
Prolonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended.
6. How is loteprednol different from prednisolone acetate?
Loteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential.
7. Can loteprednol be used for allergic conjunctivitis?
Yes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments.
8. Is loteprednol safe after cataract surgery?
Yes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist.
9. Can loteprednol be used for viral eye infections?
No, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately.
10. What are the common side effects of loteprednol eye drops?
Common side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly.
11. Does loteprednol need to be shaken before use?
Yes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed.
12. Can loteprednol be stopped suddenly?
Stopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation.
13. Is loteprednol safe for long-term daily use?
No, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure.
14. Can contact lenses be worn while using loteprednol?
It's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor.
15. Who should avoid using loteprednol eye drops?
Patients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist.
16. Can loteprednol be used in children?
Use in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.
17. Does loteprednol cause blurred vision?
Temporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.](https://productimages.withfloats.com/tile/6a50a78cd95cad00a915a6d8.png)
![Dorzolamide eye drops IP are a prescription ophthalmic solution used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Dorzolamide belongs to a class of drugs called carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor (the fluid inside the eye), thereby lowering pressure within the eye. It is typically used two to three times daily and begins measurably lowering eye pressure within about 2 hours, though consistent long-term use is essential for sustained control. Common side effects include a temporary bitter or unusual taste in the mouth, burning or stinging on instillation, and blurred vision. Because dorzolamide is chemically a sulfonamide derivative, it should be used cautiously in patients with known sulfa allergies or significant kidney impairment, and only under an ophthalmologist's supervision. It is a Schedule H prescription-only medicine in India.
What Is Dorzolamide Eye Drops IP?
Dorzolamide Eye Drops IP is a topical prescription medication used primarily to manage glaucoma and ocular hypertension — conditions characterized by abnormally elevated pressure inside the eye that, if left uncontrolled, can damage the optic nerve and lead to progressive, irreversible vision loss.
The “IP” designation indicates the formulation conforms to standards set out in the Indian Pharmacopoeia, ensuring consistent quality, purity, and potency.
Dorzolamide belongs to the carbonic anhydrase inhibitor (CAI) class of anti-glaucoma medications. Unlike oral carbonic anhydrase inhibitors (such as acetazolamide), which act systemically and often cause more pronounced side effects, topical dorzolamide is designed to act locally within the eye, offering effective IOP reduction with comparatively lower systemic exposure — though some systemic absorption can still occur.
It is frequently prescribed either as a standalone treatment or in combination with other IOP-lowering agents, such as beta-blockers (e.g., timolol) or prostaglandin analogues, when a single agent does not achieve adequate pressure control.
How Does Dorzolamide Work? (Mechanism of Action)
Aqueous humor production – The ciliary body inside the eye continuously produces aqueous humor, the clear fluid that maintains intraocular pressure and nourishes ocular tissues.
Carbonic anhydrase enzyme – This enzyme, found in the ciliary body, plays a key role in the chemical reactions that generate bicarbonate ions, which drive fluid secretion into the eye.
Enzyme inhibition – Dorzolamide inhibits carbonic anhydrase (specifically the II isoenzyme) within the ciliary processes.
Reduced fluid production – With the enzyme inhibited, bicarbonate-dependent fluid transport slows down, resulting in decreased aqueous humor formation.
Lowered intraocular pressure – Less fluid production means less pressure buildup inside the eye, helping protect the optic nerve from pressure-related damage over time.
Clinical Indications
IndicationDetailsOpen-angle glaucomaPrimary indication; helps control chronic elevated IOPOcular hypertensionUsed to reduce elevated eye pressure even before glaucoma-related damage occursAdjunct therapyCombined with beta-blockers or prostaglandin analogues when monotherapy is insufficientPost-laser or post-surgical IOP spikesSometimes used short-term under specialist guidance
Dosage & Administration
ParameterRecommendationStandard dose (monotherapy)One drop in the affected eye(s), three times dailyStandard dose (with other IOP-lowering drops)Often reduced to twice daily when combined, per doctor's instructionsOnset of actionMeasurable IOP reduction typically begins within about 2 hoursPeak effectGenerally within a few hours of instillationIf using multiple eye dropsSpace different eye medications at least 10 minutes apartMissed doseApply as soon as remembered; skip if near the next scheduled dose — do not double upDuration of useLong-term, ongoing therapy as glaucoma is a chronic condition requiring continuous management
Note: Consistency is critical — missed doses can allow intraocular pressure to rise, increasing the risk of progressive optic nerve damage.
Key Benefits
Effectively lowers intraocular pressure in both glaucoma and ocular hypertension
Acts locally in the eye, generally producing lower systemic side effects compared to oral carbonic anhydrase inhibitors
Can be used as monotherapy or in combination with other classes of glaucoma medication for enhanced pressure control
Helps protect the optic nerve from pressure-related damage with consistent long-term use
Available in a well-established, pharmacopoeia-standardized formulation (IP grade)
Suitable for long-term, chronic disease management in glaucoma patients
Precautions
Use strictly as prescribed and do not adjust dosing without consulting your ophthalmologist
Inform your doctor if you have a known sulfonamide (sulfa) allergy, since dorzolamide is chemically related to sulfa drugs
Use with caution in patients with significant kidney (renal) impairment, due to potential for systemic absorption
Not typically recommended in patients with severe corneal disease without specialist evaluation
If using contact lenses, remove before instillation and reinsert only after the interval advised by your doctor
Regular eye pressure monitoring and follow-up visits are essential during treatment
Inform your doctor of all other eye medications and systemic drugs you are using
Avoid touching the dropper tip to the eye or any surface to prevent contamination
Side Effects
Common (Usually Mild and Temporary)
Temporary bitter or unusual taste in the mouth after application
Burning or stinging sensation on instillation
Blurred vision immediately after use
Eye redness or itching
Mild eye discomfort
Less Common / Serious (Consult Your Doctor Promptly)
Signs of an allergic reaction (rash, swelling, severe itching)
Persistent eye pain or significant vision changes
Signs of corneal problems (persistent redness, discharge, sensitivity to light)
Systemic effects related to sulfonamide sensitivity, in rare cases
If any serious or persistent symptom occurs, discontinue use and contact your ophthalmologist immediately.
Comparison: Dorzolamide vs. Other Anti-Glaucoma Therapies
TreatmentClassMechanismKey ConsiderationDorzolamide eye dropsCarbonic anhydrase inhibitorReduces aqueous humor productionSulfa-related caution; often used as adjunct therapyTimolol eye dropsBeta-blockerReduces aqueous humor production via a different pathwayCaution in asthma, heart conditionsLatanoprost / prostaglandin analoguesProstaglandin analogueIncreases aqueous humor outflowOnce-daily dosing; may darken iris/eyelash growthBrimonidineAlpha-2 agonistReduces production and increases outflowCan cause drowsiness, dry mouthOral acetazolamideSystemic carbonic anhydrase inhibitorReduces aqueous humor production systemicallyMore pronounced systemic side effects than topical dorzolamide
Key Statistics (Placeholder — Pending Clinical Reviewer Verification)
MetricValueAverage IOP reduction achieved with dorzolamide monotherapy[Placeholder – insert verified clinical trial statistic]Prevalence of open-angle glaucoma in adults over 40[Placeholder – insert epidemiological reference]Proportion of patients requiring combination glaucoma therapy[Placeholder – insert verified reference]
All statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.
Expert Insight
[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]
Price of Dorzolamide Eye Drops IP
The price of dorzolamide eye drops IP varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.
Prescription only – consult your doctor.
Conclusion
Dorzolamide Eye Drops IP play a well-established role in the long-term management of glaucoma and ocular hypertension, offering targeted, localized reduction of intraocular pressure through carbonic anhydrase inhibition. Whether used alone or alongside other classes of IOP-lowering medication, consistent, correctly timed use is essential to protect the optic nerve from progressive, irreversible damage. Because dorzolamide is a sulfonamide derivative with potential for systemic absorption, patients with sulfa allergies or kidney impairment should discuss suitability carefully with their ophthalmologist. As with all glaucoma therapy, regular monitoring and adherence to the prescribed regimen — rather than occasional or as-needed use — are what ultimately safeguard long-term vision.
Frequently Asked Questions
1. What is dorzolamide eye drops used for?
Dorzolamide eye drops are used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, helping protect the optic nerve from pressure-related damage.
2. How long does it take dorzolamide to lower eye pressure?
Dorzolamide typically begins measurably lowering intraocular pressure within about 2 hours of application, though consistent, long-term use is needed to maintain stable pressure control over time.
3. What are the side effects of dorzolamide?
Common side effects include a temporary bitter or unusual taste in the mouth, burning or stinging upon application, blurred vision, and mild eye redness or discomfort. Less commonly, allergic reactions or persistent eye irritation can occur and should be reported to a doctor.
4. Does dorzolamide affect the kidneys?
Dorzolamide is a sulfonamide derivative, and although it is applied topically with generally low systemic absorption, caution is advised in patients with significant kidney impairment. Patients with known kidney disease or sulfa allergies should inform their doctor before starting treatment.
5. How often should dorzolamide eye drops be used?
Dorzolamide is typically used three times daily as monotherapy, or twice daily when combined with other glaucoma medications, exactly as directed by your ophthalmologist.
6. Can dorzolamide be used with other glaucoma eye drops?
Yes, dorzolamide is commonly combined with beta-blockers, prostaglandin analogues, or other IOP-lowering agents when a single medication does not achieve adequate pressure control. Different eye drops should be spaced at least 10 minutes apart.
7. Is dorzolamide safe for long-term use?
Yes, dorzolamide is designed for long-term, ongoing use in chronic glaucoma management, provided it is used under regular ophthalmologist supervision with periodic eye pressure monitoring.
8. Who should not use dorzolamide eye drops?
Patients with known hypersensitivity to sulfonamides, significant kidney impairment, or specific contraindications identified by their doctor should use dorzolamide only under close medical supervision, if at all.
9. Does dorzolamide cause blurred vision?
Temporary blurred vision can occur immediately after applying dorzolamide. This is usually short-lived, but if it persists, you should consult your ophthalmologist.
10. Can dorzolamide eye drops be used with contact lenses?
It's generally recommended to remove contact lenses before applying dorzolamide and reinsert them only after the interval advised by your doctor, as certain preservatives in eye drops can affect contact lens materials.
11. What happens if I miss a dose of dorzolamide?
Apply the missed dose as soon as you remember, unless it is almost time for your next scheduled dose — in that case, skip the missed dose and continue your regular schedule. Do not double up doses.
12. Why does dorzolamide cause a bitter taste?
The bitter taste occurs because a small amount of the eye drop drains through the tear duct into the nasal passage and throat, where it can be tasted. This is a recognized, generally harmless effect of topical carbonic anhydrase inhibitors.
13. Is dorzolamide the same as timolol eye drops?
No. Dorzolamide is a carbonic anhydrase inhibitor, while timolol is a beta-blocker. Both lower eye pressure but through different mechanisms, and they are sometimes prescribed together for enhanced effect.
14. Can dorzolamide be used during pregnancy?
Use during pregnancy or breastfeeding should only occur under direct medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting dorzolamide.
15. How is dorzolamide different from oral glaucoma medications?
Topical dorzolamide acts locally in the eye and generally causes fewer systemic side effects than oral carbonic anhydrase inhibitors like acetazolamide, which act throughout the body and can cause more pronounced systemic effects.
16. Can stopping dorzolamide suddenly cause problems?
Stopping dorzolamide abruptly can allow intraocular pressure to rise again, increasing the risk of progressive optic nerve damage. Always consult your ophthalmologist before discontinuing treatment.
17. Does dorzolamide need to be refrigerated?
Storage requirements can vary by brand and formulation; always follow the storage instructions printed on your specific product's packaging or as advised by your pharmacist.](https://productimages.withfloats.com/tile/6a50a30e9569e07de66607f4.png)
![Gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription combination eye medicine that pairs a fourth-generation fluoroquinolone antibiotic (gatifloxacin) with a corticosteroid (prednisolone acetate) in a single formulation. It is used to treat steroid-responsive ocular inflammation where there is also a risk of, or existing, bacterial eye infection — most commonly after cataract or other ocular surgery, and in certain inflammatory eye conditions requiring both anti-infective and anti-inflammatory action together. Gatifloxacin fights the bacteria, while prednisolone acetate reduces inflammation, redness, and swelling. This combination is not the same as a plain antibiotic drop — because it contains a steroid, it requires closer monitoring, a defined tapering schedule, and should never be self-prescribed or used beyond the duration your ophthalmologist recommends. It is a Schedule H prescription-only medicine in India, commonly marketed under brand names such as Gatiquin P.
What Is Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension?
Gatifloxacin and prednisolone acetate ophthalmic suspension is a fixed-dose combination eye drop that brings together two distinct classes of medication in one bottle:
Gatifloxacin — a fourth-generation fluoroquinolone antibiotic effective against a broad range of gram-positive and gram-negative bacteria commonly implicated in ocular infections.
Prednisolone acetate — a corticosteroid that suppresses inflammation, swelling, and associated redness or discomfort in the eye.
This combination is typically prescribed when a clinician determines that an eye condition involves both active or potential bacterial infection and significant inflammation — a situation where using either drug alone would be insufficient. The most frequent use case is post-operative care following ocular surgery, such as cataract extraction, where inflammation control speeds recovery while the antibiotic component guards against surgical-site infection.
A commonly recognized branded version of this combination in the Indian market is Gatiquin P, and patients often search specifically for this brand name alongside the generic combination name.
How Does This Combination Work? (Mechanism of Action)
Antibacterial action (Gatifloxacin) – Gatifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to replicate their DNA, resulting in bactericidal activity against susceptible organisms.
Anti-inflammatory action (Prednisolone acetate) – Prednisolone acetate suppresses the inflammatory cascade by inhibiting phospholipase A2 and reducing the release of inflammatory mediators, which decreases swelling, redness, and discomfort.
Combined surgical/inflammatory coverage – Together, the two components address both the infective and inflammatory components of a single ocular condition, which is particularly useful in the immediate post-surgical period when both risks are elevated simultaneously.
Localized ocular delivery – As a topical suspension, the combination acts directly at the site of application, minimizing systemic absorption compared to oral antibiotics or steroids.
Clinical Indications
IndicationDetailsPost-operative inflammation with infection riskMost common use — following cataract surgery or other intraocular proceduresSteroid-responsive inflammatory ocular conditionsWhere a bacterial infection is present or risk is significantChronic anterior uveitis with secondary infection riskUsed under specialist supervisionBlepharoconjunctivitis with inflammatory componentWhen combined anti-infective and anti-inflammatory action is clinically indicated
Not indicated for: viral eye infections (e.g., herpes simplex keratitis), fungal eye infections, mycobacterial infections, or uncomplicated bacterial conjunctivitis without an inflammatory component — a steroid is not appropriate in these settings.
Dosage & Administration
ParameterRecommendationStandard dose1–2 drops in the affected eye, typically 4 times daily, or as directedPost-surgical regimenOften started with a higher frequency and gradually tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationDetermined by your ophthalmologist; steroid-containing drops are not for indefinite useTaperingMust be tapered gradually rather than stopped abruptly, especially after prolonged useContact lensesAvoid wearing contact lenses during treatment unless your doctor advises otherwiseMissed doseApply as soon as remembered; do not double the next dose
Important: Never extend use beyond the prescribed duration or restart the medication without consulting your ophthalmologist, as prolonged steroid exposure carries specific ocular risks (see Precautions below).
Key Benefits
Provides dual-action therapy — infection control and inflammation control — in a single formulation
Reduces the need for two separate eye drop regimens after surgery, simplifying the treatment schedule
Speeds resolution of post-surgical redness, swelling, and discomfort while covering infection risk
Broad-spectrum antibacterial coverage from a fourth-generation fluoroquinolone
Commonly trusted and prescribed by ophthalmic surgeons as part of standard post-operative protocols
Available in a suspension formulation designed for effective ocular surface contact time
Precautions
Use strictly under ophthalmologist supervision — this is not an over-the-counter product
Not suitable for viral, fungal, or mycobacterial eye infections
Long-term or unsupervised steroid use can raise intraocular pressure (IOP) and increase glaucoma risk
Prolonged use may increase the risk of posterior subcapsular cataract formation
Steroid component may mask signs of a worsening infection or delay wound healing if misused
Regular monitoring of intraocular pressure is recommended with extended use
Inform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting
Shake the suspension well before each use for accurate dosing
Avoid touching the dropper tip to the eye or any surface
Side Effects
Common (Usually Mild and Temporary)
Transient burning or stinging on instillation
Blurred vision immediately after application
Eye discomfort or foreign-body sensation
Mild eye redness
Less Common / Serious (Consult Your Doctor Promptly)
Increased intraocular pressure / glaucoma symptoms (eye pain, halos around lights)
Delayed wound healing at a surgical site
Secondary or masked ocular infection
Signs of cataract progression with prolonged use
Corneal or scleral thinning (rare, with extended steroid exposure)
Allergic reaction (eyelid swelling, itching, rash)
Discontinue and consult your ophthalmologist immediately if any serious symptom develops.
Comparison: Combination vs. Standalone Therapies
TreatmentCompositionBest Suited ForKey ConsiderationGatifloxacin + Prednisolone acetate suspensionAntibiotic + steroidPost-surgical care; infection + inflammation togetherRequires tapering; steroid monitoring neededGatifloxacin eye drops (alone)Antibiotic onlyUncomplicated bacterial conjunctivitis/keratitisNo steroid-related risk, but no anti-inflammatory actionPrednisolone acetate eye drops (alone)Steroid onlyNon-infectious inflammatory conditions (e.g., uveitis)Not appropriate if active infection is presentPlain lubricant/antibiotic-only regimensVariesMild post-op cases without significant inflammationMay be insufficient for higher-risk surgical cases
Key Statistics (Placeholder — Pending Clinical Reviewer Verification)
MetricValueReported post-operative infection rate reduction with prophylactic use[Placeholder – insert verified clinical trial statistic]Typical duration of post-cataract-surgery combination therapy[Placeholder – insert verified reference range]Incidence of steroid-induced IOP elevation with short-course use[Placeholder – insert epidemiological reference]
All statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.
Expert Insight
[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]
Price of Gatifloxacin and Prednisolone Acetate Ophthalmic Suspension
The price of this combination suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.
Prescription only – consult your doctor.
Conclusion
Gatifloxacin and prednisolone acetate ophthalmic suspension serves an important clinical role wherever bacterial infection risk and ocular inflammation occur together — most notably in the sensitive period following eye surgery. By combining a potent fourth-generation antibiotic with a well-established corticosteroid, this formulation streamlines post-operative and steroid-responsive inflammatory care into a single, clinician-directed regimen. Because the steroid component carries specific long-term risks — including elevated eye pressure, cataract progression, and delayed healing if misused — this medication should always be used exactly as prescribed, for the duration recommended, and with appropriate tapering and follow-up. Patients should never self-adjust dosing or extend use without their ophthalmologist's explicit guidance.
Frequently Asked Questions
1. What is Gatifloxacin and prednisolone acetate ophthalmic suspension used for?
It is used to treat eye conditions that involve both inflammation and a risk of bacterial infection — most commonly after eye surgery such as cataract surgery, where it reduces post-operative swelling and redness while protecting against infection.
2. Is Gatifloxacin eye drops safe for children?
Gatifloxacin eye drops are generally considered usable in children for appropriate bacterial eye infections under a pediatric ophthalmologist's guidance. However, the gatifloxacin-prednisolone combination includes a steroid, which requires closer specialist supervision in children due to potential effects on eye pressure and healing, so it should only be used if specifically prescribed for a child.
3. What is Gatifloxacin and prednisolone acetate ophthalmic suspension (Gatiquin P) used for?
Gatiquin P is a branded formulation of gatifloxacin and prednisolone acetate ophthalmic suspension. It is used for the same core purpose — managing post-surgical or steroid-responsive ocular inflammation where there is also a bacterial infection risk, most often following cataract or other intraocular surgery.
4. Is prednisolone acetate safe for eyes?
Prednisolone acetate is a corticosteroid that is generally safe for eyes when used exactly as prescribed and for the recommended duration under an ophthalmologist's supervision. However, unsupervised or prolonged use can raise intraocular pressure, increase glaucoma risk, contribute to cataract formation, and delay wound healing, so it should never be used without medical guidance or beyond the prescribed course.
5. How is this eye drop different from regular antibiotic eye drops?
Regular antibiotic eye drops only target bacteria, while this combination also contains a steroid to control inflammation. This dual action is useful specifically when both infection risk and significant inflammation are present, such as after eye surgery.
6. How long should I use gatifloxacin and prednisolone acetate suspension?
Duration is determined by your ophthalmologist based on your specific condition, often following a tapering schedule after surgery. It should not be used longer than prescribed, and stopping should be discussed with your doctor rather than done abruptly.
7. Can this eye drop increase eye pressure?
Yes, because it contains a steroid, prolonged or unsupervised use can raise intraocular pressure. Regular monitoring is recommended, especially with extended use or in patients with a history of glaucoma.
8. Can I use this suspension for a common bacterial eye infection without inflammation?
This combination is generally reserved for cases where both infection risk and notable inflammation are present, such as post-surgical care. For uncomplicated bacterial conjunctivitis without significant inflammation, your doctor may prescribe an antibiotic-only formulation instead.
9. Do I need to shake the bottle before use?
Yes. This is a suspension, so the bottle should be shaken well before each use to ensure even distribution of both active ingredients.
10. Can this eye drop be used for viral or fungal eye infections?
No. This combination is not appropriate for viral, fungal, or mycobacterial eye infections, since it contains a steroid that can worsen these conditions if used inappropriately.
11. What are the signs I should stop using this eye drop and see my doctor?
Increasing eye pain, blurred vision that doesn't improve, halos around lights, worsening redness, or signs of an allergic reaction warrant immediate medical attention.
12. Can this eye drop be used after cataract surgery?
Yes, this combination is commonly prescribed after cataract surgery to manage post-operative inflammation while covering the risk of surgical-site infection during the healing period.
13. Does this medication require a prescription?
Yes, gatifloxacin and prednisolone acetate ophthalmic suspension is a prescription-only (Schedule H) medicine and should only be used under an ophthalmologist's direction.
14. Can contact lenses be worn during treatment?
It is generally advised to avoid wearing contact lenses while using this medication unless your ophthalmologist specifically advises otherwise, particularly during the post-surgical period.
15. What happens if I stop this eye drop too early?
Stopping too early, especially without proper tapering, may lead to a rebound of inflammation or leave a lingering infection insufficiently treated. Always follow your doctor's full course and tapering instructions.
16. Is this eye drop safe for long-term daily use?
No — because it contains a steroid, it is intended for short-term, supervised use rather than long-term daily use. Extended use significantly raises the risk of elevated eye pressure and cataract.
17. Can this suspension be used in both eyes at once?
It can be used in both eyes if both are affected and your doctor has prescribed it for bilateral use; otherwise, apply only to the eye(s) specifically directed by your ophthalmologist.](https://productimages.withfloats.com/tile/6a509bf79c2198e9ddf06962.png)
